Evidence map›Paper›PMID 38635646›Full record

ArticlePLOS global public health2024

Uptake of Human Papilloma Virus vaccine among young women living in fishing communities in Wakiso and Mukono districts, Uganda.

Muteebwa Laban, Gertrude Nanyonjo, Mathias Wambuzi, Ali Ssetaala, Geofrey Basalirwa, Dan Muramuzi, Jacqueline Kyosiimire Lugemwa, Brenda Okech, Ali Mirzazadeh

Abstract read
In one paragraph

Article in PLOS global public health, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Muteebwa LabanSchool of Medicine, College of Health Sciences, Makerere University, Kampala, Uganda.ORCID https://orcid.org/0000-0002-5807-5799
Gertrude NanyonjoDepartment of Community Studies, UVRI-IAVI HIV Vaccine Program, Entebbe, Uganda.ORCID https://orcid.org/0000-0002-1485-8222
Mathias WambuziDepartment of Community Studies, UVRI-IAVI HIV Vaccine Program, Entebbe, Uganda.
Ali SsetaalaDepartment of Community Studies, UVRI-IAVI HIV Vaccine Program, Entebbe, Uganda.ORCID https://orcid.org/0000-0003-2156-3024
Geofrey BasalirwaDepartment of Community Studies, UVRI-IAVI HIV Vaccine Program, Entebbe, Uganda.
Dan MuramuziSchool of Public Health, College of Health Sciences, Makerere University, Kampala, Uganda.ORCID https://orcid.org/0000-0002-0193-6252
Jacqueline Kyosiimire LugemwaDepartment of In-vitro studies, Uganda Virus Research Institute, Entebbe, Uganda.ORCID https://orcid.org/0000-0001-7868-9504
Brenda OkechDepartment of Community Studies, UVRI-IAVI HIV Vaccine Program, Entebbe, Uganda.ORCID https://orcid.org/0000-0002-1722-5156
Ali MirzazadehDepartment of Epidemiology and Biostatistics, Institute for Global Health Sciences, University of California San Francisco, San Francisco, California, United States of America.ORCID https://orcid.org/0000-0002-0478-3220

Funding

International Traineeships in AIDS Prevention Studies (ITAPS)R25MH123256 · NIMH · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI CHRISTINA P LINDAN · 2020 to 2026
$1.8M
NIMH NIH HHS R25 MH123256
6 · The paper itself

Abstract

Human Papilloma Virus (HPV) is a preventable cause of cervical cancer, the commonest cancer among women in Uganda. The Uganda Ministry of Health included the HPV vaccine in the free routine immunization schedule since 2015. Five years after this policy, we assessed the uptake of the HPV vaccine and associated socio-demographic factors among young women living in fishing communities in Central Uganda in 2020. We analyzed secondary data from 94 young women aged 9-25 years who were recruited from the two fishing communities (Kasenyi landing site and Koome Island) in a primary study that aimed to promote awareness of maternal and childhood vaccines. We assessed uptake of the HPV vaccine as the proportion of participants who self-reported to have ever received at least one dose of the HPV vaccine. We assessed the socio-demographic factors associated with HPV vaccine uptake using a modified Poisson regression model adjusted for clustering by study site in STATA version 17. The mean (standard deviation) age of study participants was 21.1 (3.1) years and most (81.9%) of them were from Kasenyi landing site. The uptake of the HPV vaccine was 10.6% [95% Confidence Interval (CI) 5.6, 18.9]. After adjusting for covariates, being 13-19 years old (adjusted prevalence ratio [aPR] 5.52, 95%CI 1.69, 18.00) and of Catholic religion (aPR 5.55, 95%CI 1.53, 20.16) were significantly associated with HPV vaccine uptake. The HPV vaccine uptake was very low, despite the reported 99% national coverage of HPV vaccination program for the first dose at the end of 2019. Age and religion showed to be important determinants of the HPV vaccine uptake. Reasons for such very low uptake of HPV vaccinations need to be carefully assessed to find effective strategies to improve it.

Identifiers

PMID38635646
PMCPMC11025760

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.